GlaxoSmithKline’s Global Manufacturing and Supply capabilities comprise the best quality processes and procedures associated with the production and supply of almost every dose form in the pharmaceutical industry.
Malaysia, as a country possesses a very conducive business environment and GMS Malaysia is one of the 24 GSK global consumer healthcare manufacturing sites spread across countries. The site produces consumer healthcare over-the-counter (OTC) products for over 13 markets with Malaysia having a 45% share of market followed by Singapore and Taiwan.
GMS Malaysia has been positioned as a regional supply site for consumer healthcare OTC products within the GMS network and production from Taiwan, Thailand and Venezuela is being transferred here.
